CMP
PFE icon

Coston McIsaac & Partners’s Pfizer PFE Stock Holding History

Coston McIsaac & Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
14,289
+82
+0.6% +$2.15K 0.07% 112
2026
Q1 		$398K Buy
14,207
+102
+0.7% +$2.72K 0.09% 95
2025
Q4 		$351K Sell
14,105
-366
-3% -$9.23K 0.08% 103
2025
Q3 		$368K Buy
14,471
+172
+1% +$4.25K 0.09% 99
2025
Q2 		$346K Sell
14,299
-4,023
-22% -$93.8K 0.09% 102
2025
Q1 		$464K Buy
18,322
+2,328
+15% +$60.9K 0.14% 81
2024
Q4 		$424K Sell
15,994
-3,099
-16% -$84.1K 0.13% 86
2024
Q3 		$552K Sell
19,093
-443
-2% -$12.9K 0.16% 76
2024
Q2 		$546K Buy
19,536
+1,034
+6% +$28.5K 0.17% 70
2024
Q1 		$513K Buy
18,502
+633
+4% +$17.6K 0.16% 71
2023
Q4 		$514K Buy
17,869
+98
+0.6% +$2.96K 0.18% 70
2023
Q3 		$589K Buy
17,771
+70
+0.4% +$2.48K 0.22% 62
2023
Q2 		$649K Buy
17,701
+72
+0.4% +$2.8K 0.22% 68
2023
Q1 		$719K Buy
17,629
+635
+4% +$27.4K 0.27% 62
2022
Q4 		$870K Sell
16,994
-130
-0.8% -$6.23K 0.34% 58
2022
Q3 		$749K Buy
17,124
+33
+0.2% +$1.6K 0.34% 55
2022
Q2 		$896K Buy
+17,091
New +$871K 0.54% 45

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Coston McIsaac & Partners's PFE Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Pfizer (PFE) stake by 0.58% in Q2 2026, buying an estimated $2.15K and bringing the position to 14,289 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #112.

Coston McIsaac & Partners first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $896K in Q2 2022. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Coston McIsaac & Partners held 14,289 shares of Pfizer worth $344K as of Q2 2026.
  • Coston McIsaac & Partners bought 82 Pfizer shares in Q2 2026, an estimated $2.15K.
  • Pfizer made up 0.07% of Coston McIsaac & Partners's portfolio in Q2 2026, its #112 holding.
  • Coston McIsaac & Partners first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's Pfizer position peaked at $896K in Q2 2022.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.